Steven J. Romano

Insider Reports History

Entity
Individual
Location
C/O Dianthus Therapeutics, Inc., 7 Times Square, 43 Rd Floor, New York, NY
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven J. Romano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silence Therapeutics plc EVP and Chief R&D Officer Employee Share Option (Right to Buy) 285K Jan 2, 2025 Direct
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 22K Sep 16, 2024 Direct
Silence Therapeutics plc EVP and Chief R&D Officer Ordinary Shares 13K Jan 2, 2025 Direct
Mallinckrodt plc EVP & Chief Sci. Ofcr Ordinary Shares 0 $37.50 Jun 16, 2022 Direct
Mallinckrodt plc EVP & Chief Sci. Ofcr Employee Share Options (Right to Buy) 0 Jun 16, 2022 Direct

Insider Reports Filed by Steven J. Romano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLN Silence Therapeutics plc Jan 2, 2025 1 $0 4 Jan 6, 2025 EVP and Chief R&D Officer
SLN Silence Therapeutics plc Jan 2, 2025 0 $0 3 Jan 2, 2025 EVP and Chief R&D Officer
DNTH Dianthus Therapeutics, Inc. /DE/ Sep 16, 2024 1 $0 4 Sep 18, 2024 Director
DNTH Dianthus Therapeutics, Inc. /DE/ Sep 16, 2024 0 $0 3 Sep 18, 2024 Director
MNKPF Mallinckrodt plc Jun 16, 2022 7 $0 4 Jun 21, 2022 EVP & Chief Sci. Ofcr